{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:49:23Z","timestamp":1759366163195,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ejmech.2011.10.042","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T20:32:27Z","timestamp":1319661147000},"page":"194-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Novel octahedral Pt(IV) complex with di-n-propyl-(S,S)-ethylenediamine-N,N\u2032-di-2-(3-cyclohexyl)propanoato ligand exerts potent immunomodulatory effects"],"prefix":"10.1016","volume":"47","author":[{"given":"Djordje","family":"Miljkovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena M.","family":"Poljarevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Petkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Bla\u017eevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miljana","family":"Mom\u010dilovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Nikoli\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Saksida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislava","family":"Sto\u0161i\u0107-Gruji\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanja","family":"Grguri\u0107-\u0160ipka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor J.","family":"Sabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2011.10.042_bib1","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2011.10.042_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2165\/11316640-000000000-00000","article-title":"Cisplatin overdose: toxicities and management","volume":"32","author":"Tsang","year":"2009","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejmech.2011.10.042_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/187152010791162306","article-title":"A\u00a0better platinum-based anticancer drug yet to come?","volume":"10","author":"Olszewski","year":"2010","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2011.10.042_bib4","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1021\/jm991172d","article-title":"A\u00a0novel approach for the virtual screening and rational design of anticancer compounds","volume":"43","author":"Estrada","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2011.10.042_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0010-8545(02)00026-7","article-title":"Platinum(IV) antitumour compounds: their bioinorganic chemistry","volume":"232","author":"Hall","year":"2002","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2011.10.042_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0162-0134(00)00190-2","volume":"83","author":"Jolley","year":"2001","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2011.10.042_bib7","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1021\/jm9904250","article-title":"Synthesis and oral antitumor activity of tetrakis(carboxylato)platinum(IV) complexes","volume":"43","author":"Lee","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2011.10.042_bib8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ica.2007.09.010","article-title":"Platinum(IV) complexes with ethylenediamine-N, N\u2032-diacetate diester (R2edda) ligands: synthesis, characterization and in\u00a0vitro antitumoral activity","volume":"368","author":"Kalu\u0111erovi\u0107","year":"2008","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.ejmech.2011.10.042_bib9","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1039\/b911597h","article-title":"Synthesis, characterization, in\u00a0vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R\u00a0= Et, n-Pr)","volume":"48","author":"Kaluderovi\u0107","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2011.10.042_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/jm00106a056","article-title":"Hydrophobicity parameters for platinum complexes","volume":"34","author":"Souchard","year":"1991","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2011.10.042_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/cmdc.201000058","article-title":"Synthesis and in\u00a0vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N, N\u2032-diacetate-type ligands","volume":"5","author":"Lazi\u0107","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2011.10.042_bib12","first-page":"1787","article-title":"Expert opin. satraplatin: leading the new generation of oral platinum agents","volume":"18","author":"Bhargava","year":"2009","journal-title":"Investig. Drug"},{"key":"10.1016\/j.ejmech.2011.10.042_bib13","first-page":"1527","article-title":"Toxic effects of cis-dichlorodiammineplatinum(II) in man","volume":"63","author":"Von Hoff","year":"1979","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.ejmech.2011.10.042_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1681\/ASN.2005010102","article-title":"A\u00a0pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity","volume":"17","author":"Liu","year":"2006","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2011.10.042_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4\u00a0+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2011.10.042_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00001813-199902000-00011","article-title":"Cisplatin at clinically relevant concentrations enhances interleukin-2 synthesis by human primary blood lymphocytes","volume":"10","author":"Riesbeck","year":"1999","journal-title":"Anticancer Drug"},{"key":"10.1016\/j.ejmech.2011.10.042_bib17","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ki.2010.139","article-title":"CD4+CD25+ regulatory T cells attenuate Cisplatin-induced nephrotoxicity in mice","volume":"78","author":"Lee","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejmech.2011.10.042_bib18","first-page":"1683","article-title":"The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome, Pediatr.","volume":"24","author":"Shao","year":"2009","journal-title":"Nephrol."},{"key":"10.1016\/j.ejmech.2011.10.042_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1797.2009.01172.x","article-title":"Regulatory T cells\/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events","volume":"15","author":"Zhang","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ejmech.2011.10.042_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2011.02.018","article-title":"Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome","volume":"139","author":"Liu","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejmech.2011.10.042_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-2867-11-33","article-title":"IFN-gamma, IL-17 and TGF-beta involvement in shaping the tumor microenvironment: the significance of modulating such cytokines in treating malignant solid tumors","volume":"11","author":"Alshaker","year":"2011","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.ejmech.2011.10.042_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2249.1992.tb06989.x","article-title":"Production of reactive nitrogen intermediates by bone marrow-derived macrophages on treatment with cisplatin in\u00a0vitro","volume":"89","author":"Sodhi","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejmech.2011.10.042_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.imbio.2008.07.012","article-title":"Cisplatin primes murine peritoneal macrophages for enhanced expression of nitric oxide, proinflammatory cytokines, TLRs, transcription factors and activation of MAP kinases upon co-incubation with L929 cells","volume":"214","author":"Chauhan","year":"2009","journal-title":"Immunobiol."},{"key":"10.1016\/j.ejmech.2011.10.042_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00001813-199804000-00007","article-title":"Murine peritoneal macrophages treated with cisplatin and interferon-gamma undergo NO-mediated apoptosis via activation of an endonuclease","volume":"9","author":"Ranjan","year":"1998","journal-title":"Anticancer Drug"},{"key":"10.1016\/j.ejmech.2011.10.042_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.niox.2008.04.021","article-title":"Nitric oxide, apoptosis and macrophage polarization during tumor progression","volume":"19","author":"Weigert","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejmech.2011.10.042_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2007.04.013","article-title":"Nitric oxide, chronic inflammation and autoimmunity","volume":"111","author":"Nagy","year":"2007","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ejmech.2011.10.042_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cytogfr.2009.02.004","article-title":"Interferon-gamma: a historical perspective","volume":"20","author":"Billiau","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejmech.2011.10.042_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.ejmech.2011.10.042_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/157339906775473626","article-title":"Chronic inflammation: role of adipose tissue and modulation by weight loss","volume":"2","author":"You","year":"2006","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.ejmech.2011.10.042_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/011542650802300135","article-title":"Neurodegeneration and inflammation","volume":"23","author":"DeLegge","year":"2008","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.ejmech.2011.10.042_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10787-009-0008-x","article-title":"Chronic inflammation as a manifestation of defects in immunoregulatory networks: implications for novel therapies based on microbial products","volume":"17","author":"Bottasso","year":"2009","journal-title":"Inflammopharmacol."},{"key":"10.1016\/j.ejmech.2011.10.042_bib32","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic. Biol. Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523411007847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523411007847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:39:37Z","timestamp":1759325977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523411007847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":32,"alternative-id":["S0223523411007847"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2011.10.042","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel octahedral Pt(IV) complex with di-n-propyl-(S,S)-ethylenediamine-N,N\u2032-di-2-(3-cyclohexyl)propanoato ligand exerts potent immunomodulatory effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2011.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}